Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Concetta Elisa Onesti, Adriana Romiti, Michela Roberto, Rosa Falcone & Paolo Marchetti. (2015) Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure. Expert Review of Anticancer Therapy 15:10, pages 1183-1198.
Read now
Read now
Derek Lamont West, Sarah B White, Zhouli Zhang, Andrew C Larson & Reed A Omary. (2014) Assessment and optimization of electroporation-assisted tumoral nanoparticle uptake in a nude mouse model of pancreatic ductal adenocarcinoma. International Journal of Nanomedicine 9, pages 4169-4176.
Read now
Read now
Articles from other publishers (31)
Sandy Elmehrath, Ha L. Nguyen, Sherif M. Karam, Amr Amin & Yaser E. Greish. (2023) BioMOF-Based Anti-Cancer Drug Delivery Systems. Nanomaterials 13:5, pages 953.
Crossref
Crossref
Tadayuki Takagi, Mitsuru Sugimoto, Hidemichi Imamura, Yosuke Takahata, Yuki Nakajima, Rei Suzuki, Naoki Konno, Hiroyuki Asama, Yuki Sato, Hiroki Irie, Jun Nakamura, Mika Takasumi, Minami Hashimoto, Tsunetaka Kato, Ryoichiro Kobashi, Yuko Hashimoto, Goro Shibukawa, Shigeru Marubashi, Takuto Hikichi & Hiromasa Ohira. (2023) A multicenter comparative study of endoscopic ultrasound-guided fine-needle biopsy using a Franseen needle versus conventional endoscopic ultrasound-guided fine-needle aspiration to evaluate microsatellite instability in patients with unresectable pancreatic cancer. Clinical Endoscopy 56:1, pages 107-113.
Crossref
Crossref
Yue Zhao, Hanming Yao, Kege Yang, Shiji Han, Shangxiang Chen, Yaqing Li, Shaojie Chen, Kaihong Huang, Guoda Lian & Jiajia Li. (2022)
Arsenic trioxide-loaded nanoparticles enhance the chemosensitivity of gemcitabine in pancreatic cancer
via
the reversal of pancreatic stellate cell desmoplasia by targeting the AP4/galectin-1 pathway
. Biomaterials Science 10:20, pages 5989-6002.
Crossref
Crossref
Mitsuru Sugimoto, Tadayuki Takagi, Rei Suzuki, Naoki Konno, Hiroyuki Asama, Yuki Sato, Hiroki Irie, Yoshinori Okubo, Jun Nakamura, Mika Takasumi, Minami Hashimoto, Tsunetaka Kato, Ryoichiro Kobashi, Takuto Hikichi & Hiromasa Ohira. (2022) Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE 68:1, pages 1-10.
Crossref
Crossref
Mitsuru Sugimoto, Tadayuki Takagi, Rei Suzuki, Naoki Konno, Hiroyuki Asama, Yuki Sato, Hiroki Irie, Yoshinori Okubo, Jun Nakamura, Mika Takasumi, Minami Hashimoto, Tsunetaka Kato, Ryoichiro Kobashi, Takuto Hikichi & Hiromasa Ohira. (2021) Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients. BMC Cancer 21:1.
Crossref
Crossref
Liang Wang, Meijun Li & Fei Chen. (2021) microRNA-26a represses pancreatic cancer cell malignant behaviors by targeting E2F7. Discover Oncology 12:1.
Crossref
Crossref
Wen-Hsuan Chang, Richard A. Cerione & Marc A. Antonyak. 2021. Cancer Cell Signaling. Cancer Cell Signaling
143
170
.
Matthew Brown, Wanbin Zhang, Deyue Yan, Rajath Kenath, Le Le, He Wang, Daniel Delitto, David Ostrov, Keith Robertson, Chen Liu & Kien Pham. (2020) The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC. PLOS ONE 15:1, pages e0226917.
Crossref
Crossref
Yao Song, Bin Ji, Chen-xia Jiang, Zhi-ming Chen, Ning-hua Yao, Naofumi Mukaida & Hua Huang. (2019) IL17RB expression might predict prognosis and benefit from gemcitabine in patients with resectable pancreatic cancer. Pathology - Research and Practice 215:12, pages 152650.
Crossref
Crossref
Yonghuan Mao, Ling Xi, Quan Li, Sheng Wang, Zeling Cai, Xinhua Zhang & Chunzhao Yu. (2018) Combination of PI3K/Akt Pathway Inhibition and Plk1 Depletion Can Enhance Chemosensitivity to Gemcitabine in Pancreatic Carcinoma. Translational Oncology 11:4, pages 852-863.
Crossref
Crossref
Sufang Jiang, Ya Liu, Lining Huang, Fuzhen Zhang & Rongtian Kang. (2018) Effects of propofol on cancer development and chemotherapy: Potential mechanisms. European Journal of Pharmacology 831, pages 46-51.
Crossref
Crossref
Hongxuan Tong, Zhu Fan, Biyuan Liu & Tao Lu. (2018) The benefits of modified FOLFIRINOX for advanced pancreatic cancer and its induced adverse events: a systematic review and meta-analysis. Scientific Reports 8:1.
Crossref
Crossref
Jin Jiang, Zuguo Yuan, Yiqing Sun, Yuan Bu, Wenfeng Li & Zhenghua Fei. (2017) Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway. Biomedicine & Pharmacotherapy 96, pages 619-625.
Crossref
Crossref
Jin-Wen Song, Ying-Xia Tan, Su-Bo Li, Shi-Kun Zhang, Lu-Ming Wan, Shou-Ping Ji, Hong Zhou, Zhi-Hang Zhou & Feng Gong. (2017) Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling. Oncotarget 8:35, pages 58417-58429.
Crossref
Crossref
Adriana Romiti, Rosa Falcone, Michela Roberto & Paolo Marchetti. (2017) Tackling pancreatic cancer with metronomic chemotherapy. Cancer Letters 394, pages 88-95.
Crossref
Crossref
Magdalena Skonieczna, Tomasz Hejmo, Aleksandra Poterala-Hejmo, Artur Cieslar-Pobuda & Rafal J. Buldak. (2017) NADPH Oxidases: Insights into Selected Functions and Mechanisms of Action in Cancer and Stem Cells. Oxidative Medicine and Cellular Longevity 2017, pages 1-15.
Crossref
Crossref
Zhengle Zhang, Qingke Duan, Hengqiang Zhao, Tao Liu, Heshui Wu, Qiang Shen, Chunyou Wang & Tao Yin. (2016) Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade. Cancer Letters 382:1, pages 53-63.
Crossref
Crossref
Tao Yin, Zhengle Zhang, Bin Cao, Qingke Duan, Pengfei Shi, Hengqiang Zhao, Soriba Naby Camara, Qiang Shen & Chunyou Wang. (2016) Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine. Oncotarget 7:24, pages 37192-37204.
Crossref
Crossref
Songbo Xie, Juan Qin, Shiyu Liu, Yijun Zhang, Jun Wang, Xingjuan Shi, Dengwen Li, Jun Zhou & Min Liu. (2016) Cep70 overexpression stimulates pancreatic cancer by inducing centrosome abnormality and microtubule disorganization. Scientific Reports 6:1.
Crossref
Crossref
Jill P. Smith, David C. Whitcomb, Gail L. Matters, Randall E. Brand, Jiangang Liao, Yu-Jing Huang & Marsha L. Frazier. (2015) Distribution of Cholecystokinin-B Receptor Genotype Between Patients With Pancreatic Cancer and Controls and Its Impact on Survival. Pancreas 44:2, pages 236-242.
Crossref
Crossref
Kelvin Chan, Keya Shah, Kelly Lien, Doug Coyle, Henry Lam & Yoo-Joung Ko. (2014) A Bayesian Meta-Analysis of Multiple Treatment Comparisons of Systemic Regimens for Advanced Pancreatic Cancer. PLoS ONE 9:10, pages e108749.
Crossref
Crossref
Jill P. Smith, Timothy K. Cooper, Christopher O. McGovern, Evan L. Gilius, Qing Zhong, Jiangang Liao, Alfredo A. Molinolo, J. Silvio Gutkind & Gail L. Matters. (2014) Cholecystokinin Receptor Antagonist Halts Progression of Pancreatic Cancer Precursor Lesions and Fibrosis in Mice. Pancreas 43:7, pages 1050-1059.
Crossref
Crossref
Suparna Qanungo, Joachim D. Uys, Yefim Manevich, Anne M. Distler, Brooke Shaner, Elizabeth G. Hill, John J. Mieyal, John J. Lemasters, Danyelle M. Townsend & Anna-Liisa Nieminen. (2014) N-acetyl-l-cysteine sensitizes pancreatic cancers to gemcitabine by targeting the NFκB pathway. Biomedicine & Pharmacotherapy 68:7, pages 855-864.
Crossref
Crossref
Sarah Navina, Kevin McGrath, Jennifer Chennat, Vijay Singh, Timothy Pal, Herb Zeh & Alyssa M Krasinskas. (2014) Adequacy Assessment of Endoscopic Ultrasound-Guided, Fine-Needle Aspirations of Pancreatic Masses for Theranostic Studies: Optimization of Current Practices Is Warranted. Archives of Pathology & Laboratory Medicine 138:7, pages 923-928.
Crossref
Crossref
Sanjeev K. Srivastava, Sumit Arora, Seema Singh, Arun Bhardwaj, Courey Averett & Ajay P. Singh. (2014) MicroRNAs in pancreatic malignancy: Progress and promises. Cancer Letters 347:2, pages 167-174.
Crossref
Crossref
Ingrid Garajová, Tessa Y. Le Large, Adam E. Frampton, Christian Rolfo, Johannes Voortman & Elisa Giovannetti. (2014) Molecular Mechanisms Underlying the Role of MicroRNAs in the Chemoresistance of Pancreatic Cancer. BioMed Research International 2014, pages 1-17.
Crossref
Crossref
Enrico Andreoli, Rei Suzuki, Alvin W. Orbaek, Manoop S. Bhutani, Robert H. Hauge, Wade Adams, Jason B. Fleming & Andrew R. Barron. (2014) Preparation and evaluation of polyethyleneimine-single walled carbon nanotube conjugates as vectors for pancreatic cancer treatment. Journal of Materials Chemistry B 2:29, pages 4740.
Crossref
Crossref
Elena Kurenova, Jianqun Liao, Di-Hua He, Darrell Hunt, Michael Yemma, Wiam Bshara, Mukund Seshadri & William G. Cance. (2013) The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth. Oncotarget 4:10, pages 1632-1646.
Crossref
Crossref
Chenchen Qian, Yong Wang, Yinting Chen, Linjuan Zeng, Qiubo Zhang, Xintao Shuai & Kaihong Huang. (2013) Suppression of pancreatic tumor growth by targeted arsenic delivery with anti-CD44v6 single chain antibody conjugated nanoparticles. Biomaterials 34:26, pages 6175-6184.
Crossref
Crossref
Sumit Arora, Arun Bhardwaj, Seema Singh, Sanjeev K. Srivastava, Steven McClellan, Chaitanya S. Nirodi, Gary A. Piazza, William E. Grizzle, Laurie B. Owen & Ajay P. Singh. (2013) An Undesired Effect of Chemotherapy. Journal of Biological Chemistry 288:29, pages 21197-21207.
Crossref
Crossref
Jens Werner, Stephanie E. Combs, Christoph Springfeld, Werner Hartwig, Thilo Hackert & Markus W. Büchler. (2013) Advanced-stage pancreatic cancer: therapy options. Nature Reviews Clinical Oncology 10:6, pages 323-333.
Crossref
Crossref